2023 Complication Individual Patients 
Annals of Family Medicine
NOVEMBER 20, 2024
Background: Hypertension and depression frequently co-occur, complicating patient management and worsening outcomes. Disease-level and patient-level outcomes were mainly reported, while only three studies system-level outcomes. 13 of 15 included studies showed positive results in managing comorbidity.
Physician's Weekly
JUNE 14, 2025
They reviewed individuals referred for RC and UD between 2015 and 2023 at a single center. Individuals with prior stone interventions, additional ureteric stones, or no postoperative imaging were excluded. Preoperative CT scans were analyzed to identify those with asymptomatic renal stones. The mean stone burden was 4.5
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 13, 2025
An expert panel unveiled a preoperative cannabis use assessment tool to aid in planning informed, individualized anesthesia and analgesia patient care. An expert panel has created a preoperative cannabis use assessment tool to aid healthcare professionals in planning informed, individualized anesthesia and analgesia care for patients.
Physician's Weekly
JUNE 19, 2025
When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. It also covered related pain management and physical therapy after she returned home to New York City. The bills totaled more than $100,000.
PEMBlog
OCTOBER 18, 2024
The condition affects multiple organ systems—muscular, cardiac, and respiratory—leading to a myriad of clinical complications. When patients with DMD present in the Emergency Department (ED), an understanding of the nuanced aspects of their care is essential for optimal management.
PEMBlog
MAY 1, 2025
Well break down the virology, epidemiology, clinical presentation, and complications of Parvovirus B19. Formulate an evidence-based management plan for patients with suspected or confirmed Parvovirus B19, including those with underlying hemolytic disease or immunocompromise. UpToDate , Jun. link] Macri, Angela, and Crane, Jonathan S.
PEMBlog
APRIL 20, 2023
Rather, it can change the bleeding phenotype from severe hemophilia to mild hemophilia – thus potentially reducing the risk of complications. It is therefore no hyperbole to say that Emicizumab has been a life-changing therapy for individuals with hemophilia A who have factor VIII inhibitors (alloantibodies against factor VIII).
Expert insights. Personalized for you.
130 
Let's personalize your content